Gilead's two hepatitis C drug trials meet study goals

(Reuters) - Biotechnology company Gilead Sciences on Monday said two trials of its hepatitis C drug, the centerpiece of its oral hepatitis C treatment program, met their goals in two late-stage studies. The results are expected to be used to suppo...

Source: http://health.yahoo.net/news/s/nm/gilead-s-two-hepatitis-c-drug-trials-meet-study-goals

found it for you found it I found it found here